Drugmaker Genzyme has sold two Framingham office buildings for about $20.5 million. The facilities at 1-5 Mountain Road was sold in a transaction closed May 22 to a limited liability company with ...

FRAMINGHAM — Sanofi Genzyme is doubling down on its investment in the Framingham ... With some 5,000 workers in Massachusetts, Sanofi Genzyme continues to be the state’s largest employer in ...

Biotechnology researcher Genzyme Corp. broke ground Wednesday on a $124 million, 177,00-square-foot facility in Framingham, Mass. The new site will consist of a six-story research facility and a ...

Senior executives at Genzyme opened their six-story, glass-covered biologics manufacturing facility to the public on Monday, celebrating the official opening of a building that's been occupied by ...

FRAMINGHAM, MA-Genzyme Corp acquires a protein manufacturing facility in Belgium, and decides to suspend development of a protein production plant here near the company's campus. The Belgium-based ...

Genzyme (GENZ) says it will double the size of its newest Massachusetts manufacturing facility in Framingham, Massachusetts to nearly 2 million square feet over the next ten years, ...

The International Brotherhood of Electrical Workers Local 103, a large local union, brought its campaign against the state's biotech bill to Genzyme Corp.'s campus here yesterday.

Genzyme says that, barring validation and regulatory hiccups, it expects to begin providing Fabry disease sufferers with Fabrazyme produced at its new Framingham, MA, plant beginning the first.

Genzyme says it has polished its manufacturing act. ... provided FDA finally gives its blessing to a new production facility in Framingham, MA. Genzyme, of course, ...

Sanofi-owned Genzyme said today it will build a new $80 million downstream processing facility for its Fabry disease treatment adjacent to its new Fabrazyme® (agalsidase beta) cell culture ...